Anic Equity¶
'#---------------------------------------------------------#'
Total return since start: 0.705 %¶
'#---------------------------------------------------------#'
Equity now: -----------------------------> 52085.44 Kr¶
Max Equity ever reached: ------------> 53120.35 Kr¶
Portfolio value: --------------------------> 47919.11 Kr¶
PnL: ---------------------------------------> -1007.39 Kr¶
DD now: ---------------------------------> -1.948 %¶
Max portfolio DD since start: ----> -13.025 %¶
Updated:¶
'2023-06-13 17:13:00.848774'
Anic Portfolio Holdings¶
| volume | changePercent | value | profit | profitPercent | acquiredValue | |
|---|---|---|---|---|---|---|
| name | ||||||
| Nederman Holding | 11 | 3.880000 | 2354.000000 | 165.000000 | 7.540000 | 2189.000000 |
| Xvivo Perfusion | 3 | 2.450000 | 877.500000 | 32.500000 | 3.850000 | 845.000001 |
| Svolder B | 35 | 2.030000 | 2199.750000 | 26.250000 | 1.210000 | 2173.500000 |
| BHG Group | 49 | -5.410000 | 659.050000 | 20.050000 | 3.140000 | 638.999984 |
| Biotage | 4 | 0.580000 | 622.000000 | 19.000000 | 3.150000 | 603.000000 |
| Eastnine | 6 | -2.430000 | 673.200000 | 16.200000 | 2.470000 | 657.000000 |
| Addtech B | 3 | 1.620000 | 714.600000 | 14.600000 | 2.090000 | 699.999999 |
| SynAct Pharma | 9 | -2.270000 | 658.800000 | 13.800000 | 2.140000 | 645.000003 |
| Embracer Group B | 26 | 0.150000 | 675.090000 | 13.090000 | 1.980000 | 661.999988 |
| Vitrolife | 3 | 2.040000 | 689.400000 | 12.400000 | 1.830000 | 677.000001 |
| Sdiptech B | 3 | 0.140000 | 830.400000 | 8.400000 | 1.020000 | 822.000000 |
| Indutrade | 5 | 1.220000 | 1326.500000 | 6.500000 | 0.490000 | 1320.000000 |
| Addnode Group B | 6 | 1.200000 | 758.400000 | 6.400000 | 0.850000 | 751.999998 |
| Fortnox | 10 | 4.110000 | 673.600000 | 5.600000 | 0.840000 | 668.000000 |
| Latour B | 2 | 1.570000 | 453.000000 | 4.000000 | 0.890000 | 449.000000 |
| NCC A | 6 | 1.840000 | 598.800000 | -0.200000 | -0.030000 | 598.999998 |
| NCC B | 7 | -0.800000 | 653.450000 | -0.550000 | -0.080000 | 653.999997 |
| Volati | 5 | -3.370000 | 573.000000 | -1.000000 | -0.170000 | 574.000000 |
| Nolato B | 12 | -1.820000 | 646.200000 | -1.800000 | -0.280000 | 648.000000 |
| Profoto Holding | 7 | -0.480000 | 578.200000 | -3.800000 | -0.650000 | 581.999999 |
| Sampo Oyj SDB | 1 | -0.600000 | 499.000000 | -6.000000 | -1.190000 | 505.000000 |
| SCA A | 4 | 0.000000 | 590.400000 | -8.600000 | -1.440000 | 599.000000 |
| Investor B | 3 | 0.580000 | 649.350000 | -8.650000 | -1.310000 | 657.999999 |
| BONESUPPORT HOLDING | 10 | -1.700000 | 1212.000000 | -12.000000 | -0.980000 | 1224.000000 |
| Lime Technologies | 2 | -2.190000 | 581.000000 | -12.000000 | -2.020000 | 593.000000 |
| Humana | 40 | 2.110000 | 656.800000 | -17.200000 | -2.550000 | 674.000000 |
| Lundin Gold | 7 | 0.770000 | 917.000000 | -57.000000 | -5.850000 | 973.999999 |
| Creades A | 7 | 1.290000 | 548.800000 | -62.200000 | -10.180000 | 610.999998 |
| Ambea | 68 | 0.550000 | 2472.480000 | -64.520000 | -2.540000 | 2537.000032 |
| Balco Group | 39 | -2.830000 | 1807.650000 | -67.350000 | -3.590000 | 1874.999997 |
| Gaming Innovation Group | 161 | 1.790000 | 4113.550000 | -74.450000 | -1.780000 | 4187.999942 |
| Investor A | 16 | 0.420000 | 3470.400000 | -74.600000 | -2.100000 | 3545.000000 |
| New Wave B | 40 | -1.470000 | 3762.800000 | -153.200000 | -3.910000 | 3916.000000 |
| Wästbygg Gruppen B | 80 | -1.470000 | 2688.000000 | -183.000000 | -6.370000 | 2871.000000 |
| Sedana Medical | 135 | -6.460000 | 4144.500000 | -186.500000 | -4.310000 | 4330.999935 |
| Bactiguard Holding B | 37 | -2.920000 | 2582.600000 | -384.400000 | -12.960000 | 2966.999993 |
| TOTAL | 47911.270000 | -1015.230000 | -1.963% | 48926.499863 |
Updated:¶
'2023-06-13 17:11:59.640731'
None
Last optimization/rebalancing:¶
'2023-05-05'
Next optimization/rebalancing:¶
'2023-06-15'
AVAN-Live vs backtest and OMXSE30 2023¶
Walk forward test results - depending on starting day¶
Equity is shown as log of returns. Returns range by a factor of 10. Best is about 10000%, 100 times money, and worst 1000%, 10 times money in 20 years. Maximal duration for drawdown periods vary between 280-750 days. Worst drawdown across the tests is about 40 %. ¶
